Category: neuroendocrine cancer
Dr. Matthew H. Kulke to be Featured Guest for CCF’s Luncheon with the Experts
Matthew H. Kulke, MD, medical oncologist and hematologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 27 from 12 noon to 1 pm, Eastern Time. Dr. Kulke is the Chief of Hematology/Oncology, Co-Director …
READ MORE
Dr. Nancy Sharma to be Featured Guest for Luncheon with the Experts
Nancy Sharma, MD, medical oncologist and hematologist at Swedish Cancer Institute in Issaquah, Washington, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 20 from 12 noon to 1 pm, Eastern Time.
Growing up …
READ MORE
Detectnet (copper Cu 64 dotatate injection) Now Included in NCCN Guidelines® for Neuroendocrine Tumors
The newest FDA-approved PET imaging agent for neuroendocrine tumors — DetectnetTM (copper Cu 64 Dotate injection) — is now included in the National Comprehensive Cancer Network ® (NCCN) Clinical Practice Guidelines in Oncology – Neuroendocrine…
READ MORE
Dr. Boris Naraev to be Featured Guest for Luncheon with the Experts
Boris Naraev, MD, PhD, FACP, medical oncologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, April 22 from 12 noon to 1 pm, Eastern Time. Dr. Naraev leads the Neuroendocrine Oncology Program at Banner…
READ MORE
Dr. Lale Kostakoglu-Shields to Be Featured Guest for Luncheon with the Experts
Lale Kostakoglu-Shields, MD, MPH, a nuclear medicine expert, will be the featured guest for CCF’s Luncheon with the Experts on Thursday, April 15, 2021 from 12 noon to 1 pm, Eastern Time. Dr. Kostakoglu-Shields is a professor of radiology and medical…
READ MORE
Dr. Ebrahim Delpassand to be Featured Guest for CCF’s Luncheon with the Experts
Ebrahim S. Delpassand, MD, FACNM, Chairman and Medical Director at Excel Diagnostics & Nuclear Oncology Center in Houston, Texas and founder, Chairman of the Board, and CEO of Radiomedix in Houston, will be the featured guest for Luncheon with the…
READ MORE
CCF Releases New Video on Surgery for Neuroendocrine Tumors
Many doctors have historically considered surgery the first and best option for treating a neuroendocrine tumor (NET), when appropriate for their patients. But with all the treatments that have emerged over the past 10 years, as well as new perspectives…
READ MORE
NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients
A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…
READ MORE
2020 Monica Warner Award: Call for Nominations
Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award! AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…
READ MORE
Progastrin, Novel Blood-Based Biomarker for Detection of Neuroendocrine Neoplasms
Clinicians and researchers at the University of Kentucky Division of Medical Oncology, College of Pharmacy, School of Medicine and Department of Surgical Oncology; ECS Progastrin in Switzerland; Centre Hospitalier Lyon-Sud in France; and Biospecimen…
READ MORE
